|
|
|
Volumn 2, Issue 11, 1998, Pages 867-
|
|
MDR-TB and the developing world - A problem no longer to be ignored: The WHO announces 'DOTS plus' strategy: Editorial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISONIAZID;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
EDITORIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
RETREATMENT;
TREATMENT FAILURE;
TREATMENT PLANNING;
TUBERCULOSIS;
WORLD HEALTH ORGANIZATION;
DEVELOPING COUNTRIES;
HUMANS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0031736705
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (44)
|
|
References (3)
|